BETA: Please send your feedback!
Hunter Douglas
HDG-NL:AMS
Home Furnishings
$0
MID cap
$44.58
(-0.29%)
0.03%
since start of 2019
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 1983
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Ralph Sonnenberg | Chairman & Chief Executive Officer | Male |
| Leen Reijtenbagh | CFO, Secretary, VP & Head-Investor Relations | Male |
| David H. Sonnenberg | Co-President & Co-Chief Operating Officer | Male |
| Christopher C. King | Vice President & General Counsel | Male |
| Marko H. Sonnenberg | Co-President & Co-Chief Operating Officer | Male |
| Henry Sonnenberg | Founder | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Celldex Therapeutics - Competitors and Related Companies
How Celldex Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Celldex Therapeutics
CLDX:NAS
Biotechnology
$34.84mm
SMALL cap
$2.32
(-0.11%)
-0.43%
since start of 2019
-0.62
Loading…